Optalert Pushes Further into Medtech, Appointing Experienced Technology Commercialisation Specialist, Christine Cussen to its Board.

Tuesday, 14 September 2021 Optalert, the world’s leader in drowsiness and alertness detection, today appointed Non-executive Director Ms Christine Cussen to its board.  Ms Cussen has a long and distinguished career with decades of executive and board experience across diverse industry sectors in listed, private and government sectors including global pharmaceutical, biotechnology, medical, industrial, and …

Optalert Pushes Further into Medtech, Appointing Experienced Technology Commercialisation Specialist, Christine Cussen to its Board. Read More »